Shoulder Innovations reported a Q4 net loss of $7.77M (‑$0.38/share), versus a $3.79M loss in Q4 2024, an increase of $3.98M (~105% year-over-year). The wider loss indicates deteriorating fundamentals for the medical-technology company; no revenue or guidance figures were provided in the release.
Shoulder Innovations reported a Q4 net loss of $7.77M (‑$0.38/share), versus a $3.79M loss in Q4 2024, an increase of $3.98M (~105% year-over-year). The wider loss indicates deteriorating fundamentals for the medical-technology company; no revenue or guidance figures were provided in the release.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly negative
Sentiment Score
-0.60
Ticker Sentiment
